DIETHYLCARBAMAZINE CITRATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for diethylcarbamazine citrate and what is the scope of freedom to operate?

Diethylcarbamazine citrate is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for diethylcarbamazine citrate.

Summary for DIETHYLCARBAMAZINE CITRATE

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	5
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	3
Patent Applications:	592
DailyMed Link:	DIETHYLCARBAMAZINE CITRATE at DailyMed

Recent Clinical Trials for DIETHYLCARBAMAZINE CITRATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Regional Hospital of Agboville, Southern Cote d'Ivoire	Phase 3
Case Western Reserve University	Phase 3
Washington University School of Medicine	Phase 3

See all DIETHYLCARBAMAZINE CITRATE clinical trials

Medical Subject Heading (MeSH) Categories for DIETHYLCARBAMAZINE CITRATE

Filaricides
Lipoxygenase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for DIETHYLCARBAMAZINE CITRATE

P02CB	Piperazine and derivatives
P02C	ANTINEMATODAL AGENTS
P02	ANTHELMINTICS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for DIETHYLCARBAMAZINE CITRATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lederle	HETRAZAN	diethylcarbamazine citrate	TABLET;ORAL	006459-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.